Friday Satellite Symposia
Lymphomas, Clinical Research, Education, Diseases, Treatment Considerations, Lymphoid Malignancies, Adverse Events
Seaport Ballroom ABCD
(Manchester Grand Hyatt San Diego)
Chair:
Jeremy S. Abramson, MD, Massachusetts General Hospital Cancer Center
Disclosures:
Abramson: AbbVie Inc: Consultancy; Cellectis: Research Funding; Incyte Corporation: Consultancy; Genmab US Inc: Consultancy; Genentech, a member of the Roche Group: Consultancy; Century Therapeutics: Consultancy; Seagen Inc.: Research Funding; Merck: Research Funding; Mustang Bio: Research Funding; Caribou Biosciences Inc: Consultancy; BeiGene Ltd: Consultancy; Interius BioTh: Consultancy; AstraZeneca Pharmaceuticals LP: Consultancy; Bristol Myers Squibb: Consultancy, Research Funding; Epizyme Inc: Consultancy; Foresight Diagnostics: Consultancy.
Speakers:
Jennifer L. Crombie, MD, Dana-Farber Cancer Institute
,
Martin Hutchings, MD, PhD, Copenhagen University Hospital - Rigshospitalet
,
Matthew Lunning, DO, University of Nebraska Medical Center
and
Tycel J. J. Phillips, MD, City of Hope
Disclosures:
Crombie: Merck: Research Funding; Genentech/Roche: Research Funding; Bayer: Research Funding; Abbvie: Research Funding; Genentech: Consultancy; Genmab/Abbvie: Consultancy; Seagen: Consultancy; Regeneron Pharmaceuticals, Inc.: Consultancy; ADCT: Consultancy. Hutchings: BMS/Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; AbbVie: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; AstraZeneca: Membership on an entity's Board of Directors or advisory committees, Research Funding; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Genmab: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Genentech: Research Funding; Incyte: Research Funding; Janssen/J&J: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Merck: Honoraria, Membership on an entity's Board of Directors or advisory committees; Novartis: Research Funding. Lunning: Daiichi Sankyo, Fate Therapeutics, Genentech, Genmab, Ipsen, Janssen: Consultancy, Honoraria; Kite, Lilly, Incyte, Recordati, Regeneron, SeaGen, ViTToria: Consultancy, Honoraria; Abbvie, Acrotech, ADC Therapeutics, Astrazeneca, Britsol-Myers Squibb, Caribou, CRISPR,: Consultancy, Honoraria; AbbVie, Bristol Myers Squibb, Fate Therapeutics, Sana Therapeutics, Kite: Consultancy, Research Funding. Phillips: AbbVie Inc, Genentech, a member of the Roche Grou: Research Funding; Genentech, a member of the Roche Group.: Membership on an entity's Board of Directors or advisory committees; AbbVie Inc, ADC Therapeutics, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, BeiGene Ltd, Bristol Myers Squibb, Epizyme Inc, Genentech, a member of the Roche Group, Genmab US Inc, Gilead Sciences Inc, Incyte Corporation, Lilly, Pharmacy: Consultancy; AbbVie Inc, Genentech, a member of the Roche Group, Genmab US Inc, Merc: Membership on an entity's Board of Directors or advisory committees; Seattle Genetics, Lymphoma & Myeloma Connect: Honoraria; AbbVie, Pharmacyclics/Janssen, Bayer: Other: Scholar in Clinical Research of The Leukemia & Lymphoma Society, Research Funding.
The enduring CME-accredited video/audio recorded proceedings from this activity will be made available in mid/late January 2025. Visit the Research To Practice website for more information (www.ResearchToPractice.com).
This 2-hour CME-accredited activity – offered to both in-person and virtual attendees – will focus on the utilization of CAR T-cell therapy and bispecific antibodies in the care of patients with non-Hodgkin lymphoma. Five clinical investigators will serve as faculty for the program, one of whom will moderate. Prior to the symposium. Research To Practice (RTP) recruit 4 general medical oncologists/hematologists to consult on the project. The clinicians will participate in a working group session during which they will voice challenging questions and cases from their practices and help shape the content for the symposium. The entire session will be recorded and video segments will be adapted for presentation during the event. The agenda for the symposium will be divided into 5 modules. To begin each module, the moderator will play select video excerpts from the working group for the audience and the faculty. Moderated panel discussion will ensue to provide expert perspectives and answers to the questions introduced. A faculty member-led review of related research findings will complete each module. To make the event even more engaging, attendees will use iPads to submit their own questions and cases. Virtual attendees will have the same capability via the webcast platform.
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.